$MRAM

EVERSPIN TECHNOLOGIES INC. (MRAM): Results of Operations and Financial Condition

EVERSPIN TECHNOLOGIES INC. (MRAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mram-20260630xexx991.htm EX-99.1 Document Exhibit 99.1 Everspin Reports Unaudited Second Quarter 2026 Financial Results Chandler, AZ, August 5, 2026 —Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and manufacturer of Magnetoresistive Random Ac

Original reporting
Published Aug 5, 2026, 8:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MRAM
Bullish
high confidence
Mentioned
$MRAM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MRAMBullishMed
01

Why it matters

Traders can update near-term expectations using the disclosed Q2 revenue, gross margin, GAAP vs non-GAAP earnings, cash balance, and the Q3 revenue and EPS ranges.

02

Market read

Record quarterly revenue and Q3 guidance ranges are the primary tradable inputs, with margin and expense trajectory determining whether the market treats the quarter as durable improvement or a temporary mix shift.

03

What to watch

The guidance notes non-GAAP reconciliation is unavailable and highlights uncertainty around stock-based comp and litigation timing, which can increase earnings volatility around the next print.

Relevance 7/10Novelty 8/10Timing: after-hours filing on Aug 5, 2026, with Q3 guidance for the next quarter

Background

This is an SEC 8-K (Item 2.02) with an attached exhibit reporting preliminary unaudited Q2 2026 results and providing Q3 2026 guidance.

Company-level read

Ticker impact

$MRAMBullishHigh confidence
Context

Everspin reported Q2 2026 revenue of $18.7M, GAAP net loss of $(3.6)M, and guided Q3 revenue to $19.5M-$20.5M.

Expected impact

Moderate upside bias if investors focus on record revenue and non-GAAP profitability, but downside risk remains if GAAP losses and rising operating expenses dominate.

Evidence & confidence

The filing includes concrete quarterly results (revenue, gross margin, GAAP and non-GAAP EPS) and explicit Q3 guidance ranges, which are direct inputs to valuation and near-term positioning.

Market effects

MRAM demand signals across industrial automation, energy management, and aerospace/defense may support sentiment for persistent memory and MRAM-adjacent supply chains.

Limited direct regional read-through; primarily a US-listed semiconductor/persistent memory name.

US prime-contractor contract mention could reinforce defense-related memory procurement expectations, but scale is not quantified beyond $40M.

Counterpoint

GAAP operating expenses jumped to $14.5M from $8.7M, and GAAP net loss widened, so the stock may not sustain gains if investors anchor on GAAP profitability.

Key entities

  • Everspin Technologies, Inc.

    NASDAQ-listed MRAM persistent memory provider reporting Q2 2026 results and issuing Q3 2026 guidance.

  • US prime contractor

    Referenced as the source of initial non-product revenue under a recently signed $40M contract.

  • Microchip

    Referenced in the non-GAAP definition via foundry agreement-related engineering expenses.

Related articles

$MRAMMed

Everspin stock surges 14% on MaxLinear AI server partnership

Everspin Technologies (NASDAQ:MRAM) shares rose 14% and MaxLinear (NYSE:MXL) gained 9% after both firms announced an MOU to evaluate next-generation memory architectures for AI servers. The plan combines Everspin’s persistent low-latency MRAM with MaxLinear’s storage compression, encryption and acceleration platform, targeting data-intensive workloads and market development for cloud and enterprise customers.

$NVDAMedAI 9/10

MarketBeat Week in Review – 05/18 - 05/22

Stocks rose into the week’s close, with NVIDIA (NVDA) results and forward guidance cited as evidence of tangible demand for AI infrastructure. Retail stocks showed a mixed consumer backdrop amid inflation concerns. U.S. markets were closed Monday for Memorial Day. The review also highlighted items including SpaceX’s public S-1 filing and a Phase 2 Alzheimer’s trial miss at Biogen (BIIB).

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

$GPNMed

Global Payments Q2 Earnings Call Highlights

Global Payments (NYSE:GPN) reported Q2 results and discussed its Worldpay integration and Genius point-of-sale rollout. Management guided for about 4.5% revenue growth in 2H, margins near 43%, and cited drivers including sales-force ramp and enterprise go-lives. Q2 adjusted net revenue by segment: SMB $1.51B, Enterprise $838M, Platforms $628M. Adjusted free cash flow was $687M; net leverage just below 3.5x.